Outcomes after bioprosthetic versus mechanical mitral valve replacement for infective endocarditis in the United StatesCentral MessagePerspective

Autor: Katie J. Hogan, BS, Christopher B. Sylvester, MD, PhD, Matthew J. Wall, Jr., MD, Todd K. Rosengart, MD, Joseph S. Coselli, MD, Marc R. Moon, MD, Subhasis Chatterjee, MD, Ravi K. Ghanta, MD
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: JTCVS Open, Vol 17, Iss , Pp 74-83 (2024)
Druh dokumentu: article
ISSN: 2666-2736
DOI: 10.1016/j.xjon.2023.11.019
Popis: Objective: In patients who underwent mitral valve replacement for infectious endocarditis, we evaluated the association of prosthesis choice with readmission rates and causes (the primary outcomes), as well as with in-hospital mortality, cost, and length of stay (the secondary outcomes). Methods: Patients with infectious endocarditis who underwent isolated mitral valve replacement from January 2016 to December 2018 were identified in the United States Nationwide Readmissions Database and stratified by valve type. Propensity score matching was used to compare adjusted outcomes. Results: A weighted total of 4206 patients with infectious endocarditis underwent bioprosthetic mitral valve replacement (n = 3132) and mechanical mitral valve replacement (n = 1074) during the study period. Patients in the bioprosthetic mitral valve replacement group were older than those in the mechanical mitral valve replacement group (median 57 vs 46 y, P
Databáze: Directory of Open Access Journals